Use of unlicensed drugs and off-label drug use: focus on COVID-19-Reference-Cited by-同舟云学术

Use of unlicensed drugs and off-label drug use: focus on COVID-19

Published:2020-10-28 Issue:4S Volume: Page:120-129
ISSN:2618-8473
Container-title:Kachestvennaya klinicheskaya praktika
language:
Short-container-title:GCP

Author:

Mishinova S. A.¹^ORCID,Zhuravkov A. A.¹^ORCID,Zhuravko V. K.¹^ORCID

Affiliation:

1. FSBEI HE I.P. Pavlov SPbSMU MOH Russia

Publisher

Publishing House OKI

Subject

General Medicine

Reference29 articles.

1. COVID-19 pandemic [Internet]. European Centre for Disease Prevention and Control. 2020 [cited 5 October 2020]. Available from: https://www.ecdc.europa.eu/en/covid-19-pandemic

2. Touret F, de Lamballerie X. Of chloroquine and COVID-19. Antiviral Res. 2020;177:104762. DOI: 10.1016/j.antiviral.2020.104762

3. Kolbin AS. COVID-19 and clinical pharmacology. Klinicheskaya farmakologiya i terapiya = Clin Pharmacol Ther. 2020;29(3): (in press). (In Russ). DOI 10.32756/0869-5490-2020-3-

4. Vremennye metodicheskie rekomendatsii «Profilaktika, diagnostika i lechenie novoi koronavirusnoi infektsii (COVID-19)» Versiya 7 (utv. Ministerstvom zdravookhraneniya RF 3 iyunya 2020 g.). (In Russ.). Доступно по: https://clck.ru/Nodnb. Ссылка активна на 05.10.2020.

5. Covid-19 living Data [Internet]. Covid-nma.com. 2020 [cited 5 October 2020]. Available from: https://covid-nma.com/

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current issues related to the off-label use of drugs and their potential solutions;Real-World Data & Evidence;2024-04-10

2. A systematic review of real-world clinical practice data in COVID-19: non-interventional studies;FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology;2022-04-15

3. Prescribing Drugs not in Accordance with the Official Instructions for Medical Use (Off-label), Clinical Guidelines, Standards of Medical Care and Legal Regulation in the Russian Federation. Part 2;Rational Pharmacotherapy in Cardiology;2021-05-07

4. Safety profile assessment of drug products used for the pathogenetic treatment of COVID19;Clinical Microbiology and Antimicrobial Chemotherapy;2021